用欧洲查数据对肺结节恶性瘤风险分层进行深度学习算法的外部测试
Noa Antonissen1, Kiran Vaidhya Venkadesh1, Renate Dinnessen1
1Department of Medical Imaging, Diagnostic Image Analysis Group, Radboud University Medical Center, Route 767, Room 2.30, Radboudumc, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, the Netherlands.
Radiology
|September 16, 2025
概括
在欧洲肺癌查试验中,深度学习算法显示了肺结节恶性瘤预测的改进,与PanCan模型相比,大大减少了不确定结节的错误阳性.
科学领域:
- 放射学 放射学是一门学科.
- 人工智能的人工智能
- 在瘤学瘤学.
背景情况:
- 低剂量CT查有效降低了肺癌死亡率.
- 然而,高错误阳性率的查导致不必要的程序.
- 深度学习 (DL) 提供了改善肺结节风险分层的潜力.
研究的目的:
- 为了对DL算法进行外部验证,以估计肺结节恶性瘤风险.
- 这项研究利用了来自欧洲三个主要肺癌查试验的数据.
- 性能与已建立的泛加拿大肺癌早期检测 (PanCan) 模型进行了比较.
主要方法:
- 从丹麦肺癌查试验,多中心意大利肺癌检测试验和荷兰-比利时肺癌查试验的基线CT扫描进行了回顾性分析.
- 一个在美国数据上训练的DL算法在这些欧洲队列上进行了测试.
- 包括AUC在内的性能指标在聚合队列和不确定和大小匹配结节的特定子集中进行了评估.
主要成果:
- DL算法在聚合队列中表现出强的性能 (AUC 0.98-0.94),与PanCan模型相比.
- 在A子集 (不确定的结节) 中,DL显著优于PanCan (AUC为0.95-0.90对比0.91-0.86).
- 在100%的灵敏度下,DL实现了对不确定结节的错误阳性发现的39.4%的相对减少,并且在尺寸匹配结节 (0.79对0.60) 中的AUC更高.
结论:
- DL算法在不同欧洲查数据集的肺结节恶性病预测方面表现出卓越的性能.
- 它显著减少了错误的阳性分类,特别是对于不确定的结节.
- 这证实了DL算法在提高肺癌查准确性和效率方面的潜力.
相关概念视频
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:25Statistical Methods for Analyzing Epidemiological Data
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...